GSGraziella Alves da Silva

Graziella Alves da Silva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Graziella Alves da Silva has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Tradução, adaptação transcultural e validação psicométrica da versão brasileira da escala de benefícios e barreiras ao exercício percebidos por pacientes em diálise

    by Graziella Alves da Silva, Cid André Fidelis de Paula Gomes, Thamiê Cristina Stella, Barbara G. Miura, Jing Zheng, Renato D. Foresto, Renata Kelly de Palma, Almir V. Dibai-Filho, Luciana Maria Malosá Sampaio

    Resumo Introdução: A doença renal crônica (DRC) em diálise compromete a saúde musculoesquelética e reduz os níveis de atividade física. A Dialysis Patient-Perceived Exercise Benefits and Barriers Scale (DPEBBS) foi desenvolvida especificamente para avaliar as percepções dos pacientes em diálise sobre o exercício. Este estudo teve como objetivo traduzir, adaptar transculturalmente e avaliar as propriedades psicométricas da versão brasileira da DPEBBS (EPAD). Métodos: Foi conduzido um estudo transversal, seguindo as diretrizes do COSMIN. As propriedades psicométricas avaliadas incluíram confiabilidade, consistência interna e validade de construto. Os participantes foram recrutados no setor de hemodiálise da Unifesp. Um total de 112 adultos em diálise respondeu à DPEBBS, ao Short Form Health Survey-36 (SF-36), e foi submetido à avaliação antropométrica. O intervalo entre o teste e o reteste foi de uma semana. Análises descritivas e inferenciais foram realizadas para testar a validade e a confiabilidade. Resultados: A escala demonstrou alta estabilidade teste–reteste, com médias consistentes entre as avaliações. A consistência interna foi alta, e a confiabilidade foi sustentada por uma mínima mudança detectável baixa e por um alto coeficiente de correlação intraclasse. A validade convergente com o domínio Capacidade Funcional do SF-36 foi fraca, porém estatisticamente significativa (r = –0,326; p = 0,001), enquanto a correlação com o domínio Estado Geral de Saúde foi fraca e não estatisticamente significativa (r = –0,185; p = 0,052). A análise de consistência mostrou α = 0,885, ICC = 0,794, SEM = 4,96%, e demonstrou ausência de efeitos de piso e teto. Conclusão: A EPAD apresentou validade e confiabilidade robustas para pacientes em diálise. Apesar da adequada confiabilidade e validade, este estudo apresenta limitações, incluindo uma amostra de centro único. A EPAD pode apoiar o aconselhamento individualizado para o exercício e o planejamento da reabilitação em unidades de hemodiálise.

  • Open Access

    Translation, cross-cultural adaptation and psychometric validation of the Brazilian version of the dialysis patient-perceived exercise benefits and barriers scale

    by Graziella Alves da Silva, Cid André Fidelis de Paula Gomes, Thamiê Cristina Stella, Barbara G. Miura, Jing Zheng, Renato D. Foresto, Renata Kelly de Palma, Almir V. Dibai-Filho, Luciana Maria Malosá Sampaio

    Background: Chronic kidney disease (CKD) in dialysis patients compromises musculoskeletal health and reduces physical activity levels. The Dialysis Patient-Perceived Exercise Benefits and Barriers Scale (DPEBBS) was specifically developed to assess dialysis patients’ perceptions of exercise. This study aimed to translate, cross-culturally adapt, and evaluate the psychometric properties of the Brazilian version of the DPEBBS (EPAD). Methods: A cross-sectional study was conducted following the COSMIN guidelines. Psychometric properties assessed included reliability, internal consistency, and construct validity. Participants were recruited from the hemodialysis department of Unifesp. A total of 112 adults on dialysis completed the DPEBBS, the Short Form Health Survey-36 (SF-36), and underwent anthropometric evaluation. The interval between test–retest was one week. Descriptive and inferential analyses were performed to test validity and reliability. Results: The scale demonstrated high test–retest stability, with consistent mean scores across assessments. Internal consistency was strong, and reliability was supported by a low minimal detectable change and a high intraclass correlation coefficient. Convergent validity with the SF-36 Physical Functioning domain was weak but statistically significant (r = –0.326; p = 0.001), and the correlation with the General Health domain was weak and not statistically significant (r = –0.185; p = 0.052). Consistency analysis showed α = 0.885, ICC = 0.794, SEM = 4.96%, and demonstrated the absence of floor and ceiling effects. Conclusion: The EPAD showed robust validity and reliability for dialysis patients. Despite adequate reliability and validity, this study has limitations, including a single-center sample. The EPAD may support individualized exercise counseling and rehabilitation planning in hemodialysis units.

  • Open Access

    Properties of Measurements of Patient‐Reported Outcome Measures Physical Activity Assessment in Chronic Kidney Disease: A Systematic Review

    by Thamiê Cristina Stella, Inaê Silva Santos, Graziella Alves da Silva, Cid André Gomes, Luciana Maria Malosá Sampaio

    Background and Purpose: The assessment of physical activity (PA) using Patient‐Reported Outcome Measures (PROMs) is routine due to its easy applicability and low cost. In the context of CKD, there are several studies that evaluate PA through PROM, but there is heterogeneity in the choice of tool. Therefore, the objective of this study was to identify, evaluate and synthesize the psychometric properties of PROMs used in the assessment of PA in CKD.Methods: A systematic review was carried out according to the PRISMA guidelines in PubMed, SciELO, Medline, Lilacs and EMBASE databases. The assessment of the quality of the studies was evaluated using the COSMIN Checklist and EMPRO tool.Results: 15,137 studies were found, with 17 included. Eleven PROMs were found, of which 2 were elaborate to the CKD population: Chronic Kidney Disease Physical Activity Questionnaire (CKD‐PAQ) and Low Physical Activity Questionnaire (LoPAQ). Criterion validity was the most evaluated psychometric property. Only CKD‐PAQ shows satisfactory results in both evaluation tools for the psychometric properties evaluated.Discussion: This systematic review found no consensus in the literature for the best PROM for assessing PA in CKD. However, the CKD‐PAQ appears to be promising as the only PROM with a favorable evaluation by both COSMIN RoB and EMPRO. There is a lack of studies evaluating PA in the early stages of CKD and its responsiveness, indicating a gap in the research. COSMIN RoB and EMPRO differed from each other, showing that the choice of the evaluation tool must be guided by the evaluator's expertise and objective.Trial Registration: Systematic review registered in PROSPERO (CRD42022312143)

  • Open Access

    Wearable Devices to Diagnose and Monitor the Progression of COVID-19 Through Heart Rate Variability Measurement: Systematic Review and Meta-Analysis

    by Carlos Alberto Sanches, Graziella Alves Silva, Andre Felipe Henriques Librantz, Luciana Maria Malosa Sampaio, Peterson Adriano Belan

    Background: Recent studies have linked low heart rate variability (HRV) with COVID-19, indicating that this parameter can be a marker of the onset of the disease and its severity and a predictor of mortality in infected people. Given the large number of wearable devices that capture physiological signals of the human body easily and noninvasively, several studies have used this equipment to measure the HRV of individuals and related these measures to COVID-19. Objective: The objective of this study was to assess the utility of HRV measurements obtained from wearable devices as predictive indicators of COVID-19, as well as the onset and worsening of symptoms in affected individuals. Methods: A systematic review was conducted searching the following databases up to the end of January 2023: Embase, PubMed, Web of Science, Scopus, and IEEE Xplore. Studies had to include (1) measures of HRV in patients with COVID-19 and (2) measurements involving the use of wearable devices. We also conducted a meta-analysis of these measures to reduce possible biases and increase the statistical power of the primary research. Results: The main finding was the association between low HRV and the onset and worsening of COVID-19 symptoms. In some cases, it was possible to predict the onset of COVID-19 before a positive clinical test. The meta-analysis of studies reported that a reduction in HRV parameters is associated with COVID-19. Individuals with COVID-19 presented a reduction in the SD of the normal-to-normal interbeat intervals and root mean square of the successive differences compared with healthy individuals. The decrease in the SD of the normal-to-normal interbeat intervals was 3.25 ms (95% CI −5.34 to −1.16 ms), and the decrease in the root mean square of the successive differences was 1.24 ms (95% CI −3.71 to 1.23 ms). Conclusions: Wearable devices that measure changes in HRV, such as smartwatches, rings, and bracelets, provide information that allows for the identification of COVID-19 during the presymptomatic period as well as its worsening through an indirect and noninvasive self-diagnosis.


  • Open Access

    Wearable Devices to Diagnose and Monitor the Progression of COVID-19 Through Heart Rate Variability Measurement: Systematic Review and Meta-Analysis (Preprint)

    by Carlos Alberto Sanches, Graziella Alves Silva, Andre Felipe Henriques Librantz, Luciana Maria Malosa Sampaio, Peterson Adriano Belan

    BACKGROUND Recent studies have linked low heart rate variability (HRV) with COVID-19, indicating that this parameter can be a marker of the onset of the disease and its severity and a predictor of mortality in infected people. Given the large number of wearable devices that capture physiological signals of the human body easily and noninvasively, several studies have used this equipment to measure the HRV of individuals and related these measures to COVID-19. OBJECTIVE The objective of this study was to assess the utility of HRV measurements obtained from wearable devices as predictive indicators of COVID-19, as well as the onset and worsening of symptoms in affected individuals. METHODS A systematic review was conducted searching the following databases up to the end of January 2023: Embase, PubMed, Web of Science, Scopus, and IEEE Xplore. Studies had to include (1) measures of HRV in patients with COVID-19 and (2) measurements involving the use of wearable devices. We also conducted a meta-analysis of these measures to reduce possible biases and increase the statistical power of the primary research. RESULTS The main finding was the association between low HRV and the onset and worsening of COVID-19 symptoms. In some cases, it was possible to predict the onset of COVID-19 before a positive clinical test. The meta-analysis of studies reported that a reduction in HRV parameters is associated with COVID-19. Individuals with COVID-19 presented a reduction in the SD of the normal-to-normal interbeat intervals and root mean square of the successive differences compared with healthy individuals. The decrease in the SD of the normal-to-normal interbeat intervals was 3.25 ms (95% CI −5.34 to −1.16 ms), and the decrease in the root mean square of the successive differences was 1.24 ms (95% CI −3.71 to 1.23 ms). CONCLUSIONS Wearable devices that measure changes in HRV, such as smartwatches, rings, and bracelets, provide information that allows for the identification of COVID-19 during the presymptomatic period as well as its worsening through an indirect and noninvasive self-diagnosis.